---
title: A Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline
nct_id: NCT01889771
overall_status: COMPLETED
phase: NA
sponsor: University of Colorado, Denver
study_type: INTERVENTIONAL
primary_condition: Smoking Cessation
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01889771.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01889771"
ct_last_update_post_date: 2016-02-11
last_seen_at: "2026-05-12T06:34:43.014Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# A Cost-effectiveness Study of Nicotine Patches Distributed Through a Quitline

**NCT ID:** [NCT01889771](https://clinicaltrials.gov/study/NCT01889771)

## Key Facts

- **Status:** COMPLETED
- **Phase:** NA
- **Study Type:** INTERVENTIONAL
- **Target Enrollment:** 1495
- **Lead Sponsor:** University of Colorado, Denver
- **Conditions:** Smoking Cessation
- **Start Date:** 2010-03
- **Completion Date:** 2012-03
- **CT.gov Last Update:** 2016-02-11

## Brief Summary

The study is to understand whether distribution of two different supplies of nicotine patches through a telephone quitline has an effect on quit rates. The two different supplies are four vs. eight (in two separate four-week mailings) weeks of nicotine patches. The hypothesis is that eight weeks will be slightly more efficacious but four weeks will be more cost-effective.

## Eligibility

- **Minimum age:** 18 Years
- **Sex:** ALL
- **Healthy Volunteers:** Yes

```
Inclusion Criteria:

* All callers to the Colorado QuitLine who report currently smoking 16-20 cigarettes
* who enroll in QuitLine services
* who do not require physician approval to obtain nicotine replacement therapy
* who are willing to receive the nicotine patch

Exclusion Criteria:

* Contraindications to receiving the nicotine patch through the QuitLine without physician approval include: history of hearth disease (heart attack, chest pain, or coronary artery disease), high blood pressure, pregnancy, skin conditions such as difficult to manage psoriasis or eczema, or history of a local reaction to the nicotine patch
* those who do not complete the call in English
```

## Arms

- **Nicotine Patch (4 weeks)** (EXPERIMENTAL) — participants receive one 4-weeks supply of nicotine patches
- **Nicotine Patch (8 weeks)** (EXPERIMENTAL) — participants receive up to 8 weeks of nicotine patches in up to two 4-week supplies

## Interventions

- **Nicotine Patch** (DRUG) — nicoderm patches are distributed in two different supplies through a telephone quitline

## Primary Outcomes

- **7-day smoking abstinence** _(time frame: 7 days)_
- **6-month smoking abstinence** _(time frame: 6 months)_
- **cost-effectiveness** _(time frame: 6 months)_ — cost per quit of each study arm will be calculated based on the total costs of the intervention from actual utilization data (nicotine patch costs + counseling call costs) and quit rates

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.phases` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.minAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `armsInterventions.interventions` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01889771.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01889771*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*